|
Model Number ONYXNG20030UX |
Device Problems
Burst Container or Vessel (1074); Entrapment of Device (1212); Device Damaged by Another Device (2915); Material Deformation (2976); Positioning Problem (3009)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/02/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
An attempt was made to use one onyx frontier coronary drug eluting stent (des) to treat a lesion located in the proximal left anterior descending (lad) artery and mammary graft.The device was inspected with no issues.Negative prep was performed with no issues.The lesion was pre-dilated.The device did not pass through a previously deployed stent.Resistance was encountered when advancing the device.Excessive force was not used during delivery.It was reported that the stent wouldn't pass the lesion on the first attempt.An attempt was made to remove the stent and stent delivery system (sds), but there was difficulty removing the device from the 0.014 rapid exchange wire.Upon removal a piece of the wire frayed on the stent.The stent, sds and wire were removed.The lesion was r ewired.The stent was inspected and looked ok.The stent was re-advanced to the lesion over a new wire.Inflation was attempted, but the balloon appeared to be ruptured.The stent and sds were removed over a 0.014 rx wire.A new onyxn20030ux was advanced and implanted.The patient is alive with no injury.
|
|
Manufacturer Narrative
|
Additional information: the guidewire was examined and flushed before use with no kinks noticed.There were no difficulties noted when loading the device onto the guidewire.The balloon burst occurred on the first inflation.The device was not moved or repositioned in the lesion while inflated.The stent was not deformed due to the difficulties experienced when removing the balloon however it was believed that the rapid exchange (rx) port may have been potentially damaged.The guidewire was used successfully with a semi compliant pre dilation balloon prior to the difficulties occurring.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|